InvestorsHub Logo
Followers 0
Posts 61
Boards Moderated 0
Alias Born 01/06/2020

Re: GoIrish1776 post# 30061

Thursday, 05/14/2020 4:56:53 PM

Thursday, May 14, 2020 4:56:53 PM

Post# of 34625
Allogene recently released data from a phase one study treated relapsed/refractory non-Hodgkin lymphoma. MRKR should be completing their own phase one lymphoma study by mid 2021. This study is not to be confused with their phase two AML study. The lymphoma data was magnificent; it used to be posted on the company website under presentation slides. For some reason, all of those sides were removed Q2 2019.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News